# Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers

> **NCT01638598** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 80 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** matching placebo
- **DRUG:** Test drug
- **DRUG:** matching placebo
- **DRUG:** Test drug
- **DRUG:** Test drug
- **DRUG:** Test drug
- **DRUG:** Test drug
- **DRUG:** matching placebo
- **DRUG:** matching placebo
- **DRUG:** matching placebo

## Key facts

- **NCT ID:** NCT01638598
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01638598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01638598, "Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01638598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*